Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

September 1, 2025

Conditions

Menopause SyndromeMenopause SurgicalHot Flashes

Interventions

DRUG

Paroxetine

20 mg PO daily

DIETARY_SUPPLEMENT

Placebo

1 capsule starch

Trial Locations (1)

Instituto Hondureño de Seguridad Social, Tegucigalpa

All Listed Sponsors

lead

Universidad Nacional Autonoma de Honduras

OTHER

NCT06763484 - Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause | Biotech Hunter | Biotech Hunter